Home Vernalis

Vernalis

acquired
-
New Drug Research and Development, Manufacturer

Basic Information

Vernalis is one of the leading development-stage pharmaceutical companies in the UK, attracting promising candidate products through its commercially focused market approach. They have built a pipeline of candidates from successful collaborations with multiple global pharmaceutical enterprises as well as from their own research activities. Vernalis combines fragment-based methods, structural biology, biophysics, analytical techniques, and molecular modeling with extensive expertise in synthetic organic and medicinal chemistry to discover drugs for both established and novel targets.
Vernalis (R&D) Limited
Cambridge,England,United Kingdom
51~100 people
January 01, 1988
medical@vernalis.com